CAR-T immunotherapies: Biotechnological strategies to improve safety, efficacy and clinical outcome through CAR engineering-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR-T immunotherapies: Biotechnological strategies to improve safety, efficacy and clinical outcome through CAR engineering

Published:2019-11 Issue:7 Volume:37 Page:107411
ISSN:0734-9750
Container-title:Biotechnology Advances
language:en
Short-container-title:Biotechnology Advances

Author:

Panagopoulou Theano I.,Rafiq Qasim A.^ORCID

Funder

EPSRC

New Industrial Systems: Optimising Me Manufacturing Systems

Future Targeted Healthcare Manufacturing Hub

Publisher

Elsevier BV

Subject

Biotechnology,Bioengineering,Applied Microbiology and Biotechnology

Reference142 articles.

1. A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer;Abate-Daga;Hum. Gene Ther.,2014

2. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired;Ahmadzadeh;Blood,2009

3. Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system;Avanzi;Cell Rep.,2018

4. Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment;Beatty;Oncoimmunology,2014

5. Immune-suppressive properties of the tumor microenvironment;Becker;Cancer Immunol. Immunother.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

2. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04

3. Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development;Molecular Therapy;2023-11

4. Exploring standards for multicellular mammalian synthetic biology;Trends in Biotechnology;2022-11

5. An impedimetric immunosensor for the selective detection of CD34+ T-cells in human serum;Sensors and Actuators B: Chemical;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3